BUZZ-IntelliPharmaCeutics International Inc: Pain drug gets "fast track" status
** Canadian biotech company's U.S.-listed shares up 21 pct at $3.75 premarket
** Company said U.S. FDA granted its abuse-deterrent pain drug "fast track" status
** Fast track status expedites review of drugs intended to treat serious conditions that have few or no treatment options
** Drug, Rexista Oxycodone XR, is intended for management of pain when an around-the-clock analgesic is needed for extended period of time
** Up to Friday's close, stock had risen about 37 pct this year
© Thomson Reuters 2017 All rights reserved.